1. Comparative evaluation of the new GRPR‐antagonist 111In‐SB9 and 111In‐AMBA in prostate cancer models: Implications of in vivo stability. (13th June 2019) Authors: Lymperis, Emmanouil; Kaloudi, Aikaterini; Kanellopoulos, Panagiotis; Krenning, Eric P.; de Jong, Marion; Maina, Theodosia; Nock, Berthold A. Other Names: Maina‐Nock Theodosia guestEditor.; Nock Berthold guestEditor. Journal: Journal of labelled compounds & radiopharmaceuticals Issue: Volume 62:Number 10(2019) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗